HIV

Paul Volberding C.C. Carpenter, M.A. Fischl, S.M. Hammer, M.S. Hirsch, D.M. Jacobsen, D.A. Katzenstein, J.S. Montaner, D.D. Richman, M.S. Saag, R.T. Schooley, M.A. Thompson, S. Vella, P.G. Yeni, P.A. Volberding, "Antiretroviral therapy for HIV infection in 1996--Recommendations of an international panel," JAMA-Journal of the American Medical Association, 276:146-54, 1996. (Cited more than 180 times since publication) Comments by Paul A. Volberding, chairman of the board of the International A

The Scientist Staff
Jul 19, 1998


Paul Volberding
C.C. Carpenter, M.A. Fischl, S.M. Hammer, M.S. Hirsch, D.M. Jacobsen, D.A. Katzenstein, J.S. Montaner, D.D. Richman, M.S. Saag, R.T. Schooley, M.A. Thompson, S. Vella, P.G. Yeni, P.A. Volberding, "Antiretroviral therapy for HIV infection in 1996--Recommendations of an international panel," JAMA-Journal of the American Medical Association, 276:146-54, 1996. (Cited more than 180 times since publication)

Comments by Paul A. Volberding, chairman of the board of the International AIDS Society-USA and Director of the Center of Aids Research at the University of California at San Francisco.


" . . . we got criticized by some sides for being too aggressive, and from some for not being aggressive enough."

--Paul Volberding


Rules are made to be broken--or, in this case, amended and improved. The members of the International AIDS Society-USA (IAS), a national not-for-profit organization based in San Francisco, embarked on this 1996 study in response to HIV treatment...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?